Biotechnology and blockchain company in Dubai: licence

Biotechnology generates the most valuable — and most sensitive — data in the digital economy: genomes, medical records, clinical trials, medicine supply chains. Blockchain brings exactly what that sector needs: traceability, integrity and secure sharing without giving up control of the data. At the crossing of the two, more and more companies are being built — and whoever wants to set up their own needs, as always, a licence with the official activity that covers what they actually do.

That crossing has its own group in the official activity list of RAK DAO / Innovation City, the Ras Al Khaimah free zone specialised in digital assets, Web3 and artificial intelligence: Biotech × Blockchain, with three activities covering the data, the supply chain and the health applications. This guide breaks them down one by one: what each activity allows, where the line that none of them crosses sits — the company is technological, not medical — and how the whole is taxed.

The activity group: general map

The costs are additional to the free zone licence and come from the official list — like any published fee, it pays to confirm them with the authority before budgeting. Two of the three activities score a low risk rating; the HealthTech applications rise to medium risk, consistent with the sensitivity of the health data they touch.

The three activities, one by one

Bioinformatics data exchange (Bioinformatics Data Exchange)

It covers the use of blockchain for the secure sharing and monetisation of genomic and bioinformatics data between researchers and laboratories, preserving patient privacy. The entry places the activity at the nexus of biotechnology and blockchain and conditions its non-regulated status on there being no misuse of personal health data — the declared focus is research. Additional cost: AED 4,899.

Pharmaceutical supply chain traceability (Pharma Supply Chain Traceability)

It covers blockchain solutions to trace pharmaceutical products — from production to pharmacy — against counterfeit medicines and in favour of transparency, strictly as a technology service. It is the group’s public-good entry (health security), and its definition as a pure technology layer is what keeps it in the non-regulatory domain: the company provides the immutable record, it neither manufactures nor distributes the medicine. Additional cost: AED 8,899.

AI-driven HealthTech applications (AI-Driven HealthTech Apps)

It covers the creation of healthcare applications combining AI and blockchain for secure health data management, personalised medicine or clinical trial management — the technology only. It brings together two priority sectors (health and technology) with the limit written into the entry itself: the company remains a software provider, not a healthcare facility. It is the only one in the group with a medium risk rating. Additional cost: AED 4,899.

The limits of the group

All three entries repeat the same boundary in different words: technology layer yes, healthcare practice no. The company shares research data, it does not diagnose; it traces the medicine, it neither manufactures nor dispenses it; it builds the clinical application, it does not treat the patient. Crossing that line — operating as a health facility, dispensing products, processing patient data outside the research framework — triggers the healthcare licences and their regulators, a different conversation best had before incorporating. And the cross-cutting condition is privacy: in this group, compliance with UAE data-protection regulations is not an annex to the file but the heart of the service design. For the pure AI activities on the same list — chips, edge, ethics — there is the guide to the artificial intelligence company, and for the intensive computing layer, the guide to the high-performance computing company.

Taxation of the company

The framework is that of any technology company in the Emirates. On VAT, services to local clients are taxed at 5% and supplying clients outside the country can qualify for the 0% rate under the conditions of the regulations — and in a sector whose natural client is the international laboratory or the global pharmaceutical company, exported services are the typical case. VAT registration is mandatory once you exceed AED 375,000 of annual taxable turnover. On profits, Corporate Tax at 9% above AED 375,000. For a company mixing software licences, projects and data agreements, the accounting that classifies every flow from the first invoice prevents the problem where it usually starts.

Steps to set up the company

1. Activities and scope: choose from the group the ones that cover your actual model — and combine them under the same licence if you do more than one thing (data + applications, traceability + data).
2. Structure: a company in the free zone with the activities added, each with its own additional cost, to be confirmed with the authority.
3. File: shareholders’ KYC and a description of the model — with special attention to data processing, which is what the authority will want to understand here.
4. Incorporation and space, from a flexi desk to an office, depending on the team.
5. Visas for the founder and the technical team.
6. VAT and accounting from the start, with the 5%/0% classification defined before the first invoice.

Conclusion

The Biotech × Blockchain group resolves the paradox of a sector that handles the most sensitive data with the most transparent technology: three official activities with a published name, risk rating and additional cost, combinable under a single licence, and a clear boundary that protects the structure — technology yes, healthcare practice no. Whoever respects it, and puts privacy at the centre of the design from day one, has in Ras Al Khaimah a clean way into one of the most promising crossings on the map. The rest — the product, the data, the clients — is the hard part; the company, here, is the easy one.